Norton Neuroscience Institute Research & Clinical Trials | Norton Healthcare Louisville, Ky.

Norton Neuroscience Institute Research & Clinical Trials

Norton Neuroscience Institute is at the forefront of condition neuroscientific research. As investigators on numerous trials, our specialist physicians have unparalleled experience with many innovative treatments once they are approved for broad use. Patients also may be eligible to take part in these experimental neuroscientific treatments. Norton Neuroscience Institute researchers also contribute to groundbreaking studies and other publications in peer-reviewed journals.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Neuroscience Clinical Trials and Studies

Alzheimer’s

Alzheimer’s Disease and Related Disorders Memory Center Recruitment Database
Study Type: Registry
Greg Cooper, M.D.,Ph.D.
Greg Cooper, M.D.,Ph.D.
Principal Investigator
Norton Neuroscience Institute
Recently published research
Sponsor: NH Investigator

Alzheimer’s Disease

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Study Type: Drug Study
Greg Cooper, M.D.,Ph.D.
Greg Cooper, M.D.,Ph.D.
Principal Investigator
Norton Neuroscience Institute
Recently published research
Eligibility Criteria and Other Details
NNIResearch@nortonhealthcare.org
Sponsor: Eli Lilly

Aneurysms

STERLING REGISTRY - A Prospective, Multi-Center, Single Arm, Study to obtain “real world” clinical data and characterize the acute & long term performance of the Micrusframe & Galaxy Coils for the Endovascular treatment of Intracranial Aneurysms
Study Type: Device Study
Tom Yao M.D.
Tom Yao M.D.
Principal Investigator
Norton Neuroscience Institute
Recently published research
Eligibility Criteria and Other Details
NNIResearch@nortonhealthcare.org
Sponsor: Cerenovus, Part of Depuy Synthes Products, Inc

COVID-19 Infection

COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the US National MS Society and the Consortium of MS Centers to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica Spectrum Disease, or MOG antibody disease) who have developed COVID-19
Study Type: Registry
Geeta Ganesh M.D.
Geeta Ganesh M.D.
Principal Investigator
Norton Neuroscience Institute
Sponsor: US National MS Society / Consortium of MS Centers

Epilepsy

PENSAR: PatiEnt Neuropsychological outcomeS After laseR ablation
Study Type: Registry
Bradley Folley, Ph.D.
Bradley Folley, PhD
Principal Investigator
Norton Neuroscience Institute
Eligibility Criteria and Other Details
NNIResearch@nortonhealthcare.org
Sponsor: Monteris Medical Corporation

Multiple Sclerosis (MS)

TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial
Study Type: Observational
Geeta Ganesh M.D.
Geeta Ganesh M.D.
Principal Investigator
Norton Neuroscience Institute
Eligibility Criteria and Other Details
neuroresearch@nortonhealthcare.org
Sponsor: Johns Hopkins School of Medicine

NMOSD

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Study Type: Registry
Geeta Ganesh M.D.
Geeta Ganesh M.D.
Principal Investigator
Norton Neuroscience Institute
Eligibility Criteria and Other Details
neuroresearch@nortonhealthcare.org
Sponsor: CorEvitas, LLC

Relapsing Multiple Sclerosis (RMS)

A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing Oral SAR442168 to Oral Teriflunomide (Aubagio®) in Patients With Relapsing Forms of Multiple Sclerosis
Study Type: Drug Study
Geeta Ganesh M.D.
Geeta Ganesh M.D.
Principal Investigator
Norton Neuroscience Institute
Eligibility Criteria and Other Details
neuroresearch@nortonhealthcare.org
Sponsor: Sanofi-Aventis

Recently Published Neuroscience Research from Norton Neuroscience Institute and Norton Healthcare Physicians

RSS (Neurosciences[Mesh] or Neurology[Mesh] or Nervous System Diseases[Mesh]) AND (Norton [Affiliation]) AND (Louisville[Affiliation]) NOT (Children's[Affiliation])

Read More at Pubmed.gov

Neuro – 6390

Appointments

(502) 446-4NNI (4664)

Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Early symptoms of MS can vary widely, but will typically trace back to neurological impairment

Early symptoms of multiple sclerosis (MS) can start to appear in adolescence, but the disease tends to develop in adults between the ages of 20 and 40. MS tends to progress and can do so […]

Read Full Story

Doctor’s passion led to neurology after grandfather’s Parkinson’s diagnosis

For Jason L. Crowell, M.D., working in medicine and fighting Parkinson’s disease are personal. One of the newest neurologists on staff at Norton Neuroscience Institute, Dr. Crowell grew up watching his grandfather, a long-time physician, [...]

Read Full Story

Knowing your MS triggers can help reduce worsening symptoms or relapses

Multiple sclerosis (MS) triggers that worsen symptoms or cause a relapse can include stress, heart disease and smoking. While some are easier to avoid than others, maintaining a healthy lifestyle and overall health and wellness [...]

Read Full Story

Never felt better: Louisville native returns and gets epilepsy and migraine team care

To say the teen years aren’t easy would be an understatement for Katie Deppe. When she was 14, Katie saw several doctors for unexplained symptoms before spending two weeks at Norton Children’s Hospital, where finally […]

Read Full Story

Migraine can get in the way of work — be open with your supervisors about your condition

Migraine attacks can be debilitating, making work difficult, if not impossible. On average, people who have migraine miss 4 1/2 days of work every year because of their condition. There are 11 more days of [...]

Read Full Story
View All Stories
Related Stories

Early symptoms of MS can vary widely, but will typically trace back to neurological impairment

Early symptoms of multiple sclerosis (MS) can start to appear in adolescence, but the disease tends to develop in adults between the ages of 20 and 40. MS tends to progress and can do so […]

Read Full Story

Doctor’s passion led to neurology after grandfather’s Parkinson’s diagnosis

For Jason L. Crowell, M.D., working in medicine and fighting Parkinson’s disease are personal. One of the newest neurologists on staff at Norton Neuroscience Institute, Dr. Crowell grew up watching his grandfather, a long-time physician, [...]

Read Full Story

Knowing your MS triggers can help reduce worsening symptoms or relapses

Multiple sclerosis (MS) triggers that worsen symptoms or cause a relapse can include stress, heart disease and smoking. While some are easier to avoid than others, maintaining a healthy lifestyle and overall health and wellness [...]

Read Full Story

Never felt better: Louisville native returns and gets epilepsy and migraine team care

To say the teen years aren’t easy would be an understatement for Katie Deppe. When she was 14, Katie saw several doctors for unexplained symptoms before spending two weeks at Norton Children’s Hospital, where finally […]

Read Full Story

Migraine can get in the way of work — be open with your supervisors about your condition

Migraine attacks can be debilitating, making work difficult, if not impossible. On average, people who have migraine miss 4 1/2 days of work every year because of their condition. There are 11 more days of [...]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.